51 filings
8-K
NKGN
NKGen Biotech Inc
13 May 24
Entry into a Material Definitive Agreement
8:05am
8-K
NKGN
NKGen Biotech Inc
10 May 24
Entry into a Material Definitive Agreement
4:01pm
8-K
NKGN
NKGen Biotech Inc
29 Apr 24
Entry into a Material Definitive Agreement
4:01pm
8-K
NKGN
NKGen Biotech Inc
24 Apr 24
Entry into a Material Definitive Agreement
7:51pm
8-K
NKGN
NKGen Biotech Inc
11 Apr 24
NKGen Biotech Secures Additional Financing of $5 Million to Continue Advancing Its Clinical Programs
8:05am
8-K
jhtn6e2z
5 Apr 24
Entry into a Material Definitive Agreement
4:01pm
8-K
su5k 0h9w
27 Mar 24
Entry into a Material Definitive Agreement
4:55pm
8-K
f8fk0fyge03
20 Mar 24
Other Events
4:01pm
8-K
8syuqwp6lrh3
15 Mar 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:02pm
8-K
jh9sayaujl6hvz xib
22 Feb 24
Entry into a Material Definitive Agreement
4:01pm
8-K
vqfkxuc h2
16 Feb 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
6:00pm
8-K
mza qglopenukjfklu
12 Feb 24
Entry into a Material Definitive Agreement
9:25am
8-K
2qz37reu7m4qc
8 Feb 24
Departure of Directors or Certain Officers
5:07pm
8-K
hv9s53
22 Jan 24
Entry into a Material Definitive Agreement
6:12am
8-K
eqkzpyf5
11 Jan 24
Entry into a Material Definitive Agreement
7:50pm
8-K
13hkz83g3gqejqx
8 Jan 24
Entry into a Material Definitive Agreement
5:19pm
8-K
fmppwufodmgqsd2
28 Dec 23
Other Events
4:14pm
8-K
mrz36 t2macx19qgfw
27 Dec 23
NKGen Biotech Announces Clearance of Clinical Trial Application by Health Canada for SNK01 NK Cell Therapy to Treat Alzheimer’s Disease
4:02pm
8-K
ys0q2jak 7l9zsqfqc
27 Dec 23
Entry into a Material Definitive Agreement
4:01pm
8-K
ggk yt0kppa
14 Nov 23
NKGen Biotech, Inc. Reports Third Quarter 2023 Financial Results and Business Highlights
4:36pm